IL2RA and adult T-cell leukemia/lymphoma: These results demonstrate that both 131I- and CF750-labeled Dmab(scFv)-Fc antibodies can target CD25-positive tumors, and they might be developed as imaging agents for the diagnosis of lymphomatous types of ATLL.